What is Chengdu Kanghong Pharmaceutical Group Co., Ltd's (002773.SZ) StockRank?

MoatMap's StockRank for Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) is 75/100, with a Buy signal. This is a composite score combining Quality (84), Value (54), and Momentum (24) factor ranks across MoatMap's 19,000+ stock universe.

Does Chengdu Kanghong Pharmaceutical Group Co., Ltd have an economic moat?

Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) has a Quality factor score of 84/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Chengdu Kanghong Pharmaceutical Group Co., Ltd a buy, hold, or sell?

MoatMap's current signal for Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) is Buy, based on a StockRank of 75/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Chengdu Kanghong Pharmaceutical Group Co., Ltd in?

Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002773.SZ

BUYREMOVE

Chengdu Kanghong Pharmaceutical Group Co., Ltd · Healthcare · China · $2.9B · Avg Vol: $24M/d

StockRank

P/E (TTM)

17.7x

ROE

11.3%

D/E

0.0x

Dividend %

3.4%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Chengdu Kanghong is a domestic Chinese pharmaceutical firm focused on ophthalmic and traditional Chinese medicine. It does not possess the global CDMO pricing power or manufacturing scale required to benefit from our healthcare theme.

COMPANY DESCRIPTION

Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a biopharmaceutical company specializing in the research, development, and commercialization of ophthalmic, central nervous system, and digestive drugs. The company holds a dominant market position in China's ophthalmic biologics sector, anchored by its blockbuster proprietary biologic, Conbercept. It is characterized by its strong R&D-driven growth profile and high-margin proprietary product portfolio.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	501M	585M	658M	678M	10.6%
EPS	0.14	0.17	0.19	0.19	8.7%
Shares	919M	919M	920M	921M	+0.2%
Debt	719,122	297,259	768,736	518,341	-10.3%
Equity	1.0B	1.2B	1.3B	1.4B	10.4%
Op CF	137M	180M	209M	222M	17.6%
Inv CF	-32M	977,834	-17M	-33M	—
Fin CF	-11M	-19M	-51M	-77M	—

PRICE (1M)-18.5%

SMA 50SMA 200

$2.96

RSI (14)

43.3

52W High

$6.76

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

13.9%82.9

ROE

11.3%74.9

GP/Assets

40.2%79.2

Op. Margin

33.0%93.9

FCF/Assets

5.9%74.0

Piotroski

—83.5

Int. Cover

—N/A

D/E Ratio

0.00x99.1

Current Ratio

12.70x90.7

Value

P/E (TTM)

17.7x64.4

EV/EBITDA

8.6x46.1

P/FCF

225.7x35.7

P/B

2.0x56.0

P/S

4.3x45.6

Div Yield

3.4%76.5

Momentum

52W High %

44%16.9

RS 6M

-41%28.6

SMA 50/200

0.78x11.0

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+34%44.5

Q Growth

-23%21.8

FUNDAMENTALS

Market Cap

$2.9B

P/E (Forward)

13.2x

Gross Margin

89.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002773.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002773.SZ	Chengdu Kanghong Pharmaceutical Group Co., Ltd(you)	$2.9B	75	BUY
002262.SZ	Jiangsu Nhwa Pharmaceutical Co., LTD	$3.0B	79	BUY
000623.SZ	Jilin Aodong Pharmaceutical Group Co., Ltd.	$3.0B	69	BUY
300142.SZ	Walvax Biotechnology Co., Ltd.	$3.0B	67	BUY
603858.SS	Shandong Buchang Pharmaceuticals Co., Ltd.	$2.3B	66	BUY
600535.SS	Tasly Pharmaceutical Group Co., Ltd	$3.1B	86	STRONG BUY
002399.SZ	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$2.2B	67	BUY
002317.SZ	Guangdong Zhongsheng Pharmaceutical Co., Ltd.	$3.0B	60	HOLD
600062.SS	China Resources Double-Crane Pharmaceutical Co.,Ltd.	$2.6B	88	STRONG BUY
000739.SZ	Apeloa Pharmaceutical Co.,Ltd	$2.8B	91	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) — Stock Score Summary

Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) has a MoatMap StockRank of 75/100 based on Quality (84/100), Value (54/100), and Momentum (24/100) factor scores. The current signal is BUY. Chengdu Kanghong is a domestic Chinese pharmaceutical firm focused on ophthalmic and traditional Chinese medicine. It does not possess the global CDMO pricing power or manufacturing scale required to benefit from our healthcare theme.

Key Financial Metrics

Price	$2.96
Market Cap	$2.9B
P/E (TTM)	17.68
P/E (Forward)	13.23
Price/Book	1.97
Return on Equity	11.3%
Return on Invested Capital	13.9%
Debt/Equity	0.02
Gross Margin	89.6%
Operating Margin	33.0%
Revenue Growth	-12.7%
Dividend Yield	3.4%
Free Cash Flow	$13M

Chengdu Kanghong Pharmaceutical Group Co., Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Chengdu Kanghong Pharmaceutical Group Co., Ltd’s (002773.SZ) StockRank?: MoatMap’s StockRank for Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) is 75/100, with a Buy signal. It is a composite of Quality (84), Value (54), and Momentum (24) factor ranks across MoatMap’s 19,000+ stock universe.
Does Chengdu Kanghong Pharmaceutical Group Co., Ltd have an economic moat?: Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) has a Quality factor score of 84/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Chengdu Kanghong Pharmaceutical Group Co., Ltd a buy, hold, or sell?: MoatMap’s current signal for Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) is Buy, based on a StockRank of 75/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Chengdu Kanghong Pharmaceutical Group Co., Ltd in?: Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).